NCT05630937View on ClinicalTrials.gov

Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 13, 2020

Primary Completion Date

January 31, 2024

Study Completion Date

August 6, 2024

Conditions
Unresectable Hepatocellular Carcinoma (HCC)
Interventions
DRUG

NMS-01940153E

Route of administration: intravenous (IV) solution

Trial Locations (9)

8036

Hospital Clínic de Barcelona, Barcelona

10128

Azienda Ospedaliera Ordine Mauriziano di Torino, Torino

20089

Istituto Clinico Humanitas, Rozzano

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

35128

Istituto Oncologico Veneto - IRCCS, Padua

56126

Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara, Pisa

80145

Azienda Sanitaria Locale Napoli 1 Centro - Ospedale del Mare, Naples

92868-3201

University of California Irvine Health, Orange

63110-1032

Siteman Cancer Center - Washington University Medical Campus, St Louis

Sponsors
All Listed Sponsors
lead

Nerviano Medical Sciences

INDUSTRY

NCT05630937 - Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy | Biotech Hunter | Biotech Hunter